Roux-en-Y gastric-bypass surgery fared better than sleeve gastrectomy and optimal medical therapy in reducing A1C levels and boosting insulin sensitivity and beta-cell function in patients with diabetes, according to a study in Diabetes Care. "Gastric bypass essentially was like CPR to a failing pancreas. It was able to restore its function, and this led to durable blood sugar control for these patients," said researcher Dr. Sangeeta R. Kashyap.
RYGB outperforms drugs, gastrectomy in lowering A1C
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||